# Primary Cyto-reductive Surgery Vs Neo-adjuvant Chemotherapy (NAC) in Epithelial Ovarian Cancer

> **NCT04257786** · NA · UNKNOWN · sponsor: **Assiut University** · enrollment: 80 (estimated)

## Conditions studied

- Advanced Cancer

## Interventions

- **PROCEDURE:** 1ry cyto-reductive surgery
- **COMBINATION_PRODUCT:** Neoadjuvant chemotherapy followed by surgery

## Key facts

- **NCT ID:** NCT04257786
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-03-01
- **Primary completion:** 2021-12-30
- **Final completion:** 2022-04-01
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2020-02-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04257786

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04257786, "Primary Cyto-reductive Surgery Vs Neo-adjuvant Chemotherapy (NAC) in Epithelial Ovarian Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04257786. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*